Mergers & Acquisitions
Filter News
Found 19,155 articles
-
Greenphire Announces Strategic Growth Investment from Thoma Bravo
5/26/2021
Thoma Bravo , a leading private equity investment firm focused on the software and technology-enabled services sector, today announced that it has reached an agreement to acquire Greenphire , the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
-
WebMD Acquires ADDitude
5/26/2021
WebMD Health Corp., an Internet Brands company and a leader in health information services for consumers and healthcare professionals, announced the acquisition of ADDitude, a multi-channel platform supporting people with attention deficit hyperactivity disorder, their caregivers, and professionals in the ADHD treatment space.
-
The UK’s Competition and Markets Authority (CMA) will determine if the deal is anti-competitive.
-
NextPhase Medical Devices Acquires Proven Process Medical Devices
5/25/2021
NextPhase Medical Devices LLC, a leading provider of electronic manufacturing services (EMS) and single-use disposable devices to leading medical device OEMs, recently announced the acquisition of Proven Process Medical Devices Inc.
-
Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma
5/25/2021
Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier.
-
Henry Schein One Acquires Majority Interest in Jarvis Analytics
5/25/2021
Acquisition Strengthens Henry Schein One's Goal to be the Leading Provider of Dental Analytics Solutions and Services to the Dental Market
-
IsoPlexis acquires extensive DNA and RNA sequencing portfolio to enable integrated single-cell sequencing and proteomic solutions
5/25/2021
The integration of the sequence of each single cell coupled with IsoPlexis' proprietary functional proteomics accelerates insights into discovery biology & development of advanced medicines
-
Oxygen Plus (O+) Completes Acquisition Of California-Based Recreational Oxygen Company
5/25/2021
Oxygen Plus (O+) , the pioneer and leader in portable canisters of recreational oxygen, today announced it completed the acquisition of California -based recreational oxygen company, O2 Naked Air.
-
Aspekt Solutions Acquires Nordic Medical Physics
5/24/2021
Aspekt Solutions , a leading provider of radiation oncology and radiology solutions, is pleased to announce the acquisition of Nordic Medical Physics. This strategic acquisition increases the consulting capabilities and expands the geographic footprint of Aspekt Solutions.
-
Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
5/24/2021
Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points
-
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
5/24/2021
Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders n
-
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
5/24/2021
With this acquisition, Enveric will expand and complement its pipeline of naturally occurring cannabinoid compounds with a robust portfolio of psychedelic-derived molecules
-
Less than two weeks after Ginkgo Bioworks announced a merger with SPAC Soaring Eagle Acquisition Corp., it announced a collaboration partnership with Biogen.
-
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
5/21/2021
Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders
-
Amalgam Rx Acquires Adaptive, Conversational, Artificial Intelligence (AI) Assets
5/20/2021
Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the acquisition of the assets of Geetha, LLC, an adaptive, conversational AI company.
-
GreenLight Biosciences Acquires Bayer's topical RNA Intellectual Property portfolio
5/20/2021
GreenLight Biosciences today announced that they have acquired rights to portions of Bayer's topical RNA Intellectual Property portfolio. These assets include bee health capabilities to protect against Varroa mites, a major threat to honeybees.
-
SeaSpine Announces Closing of 7D Surgical Acquisition
5/20/2021
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical.
-
Validant Acquires Clinical Outcomes Solutions, A Global Leader in Clinical Outcomes Assessment Research Services
5/20/2021
Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (“COS”), a global leader in clinical outcomes assessments (COA).
-
Tegria Acquires Colburn Hill Group to Ease Revenue Cycle Management Challenges for Healthcare Providers
5/20/2021
Tegria today announced the acquisition of Colburn Hill Group, one of the healthcare industry's leading developers of analytically-driven robotic process automation (RPA) technologies for revenue cycle management (RCM
-
Mandos, LLC Agrees to Acquire Adrabetadex from Mallinckrodt Pharmaceuticals
5/19/2021
Today, Mandos, LLC (Mandos) announced they have entered into an agreement with Vtesse, LLC, a wholly owned subsidiary of Mallinckrodt Pharmaceuticals (Mallinckrodt), a global biopharmaceutical company, to acquire adrabetadex (also known as VTS-270), a drug in development for the treatment of Niemann-Pick Type C1 disease (NPC1).